Congenital Hypofibrinogenemia

Indian Pediatrics

Volumn 41, Issue 2, 2004, Pages 185-187

  Awasthy, Neeraj ^a   Aggarwal, K C ^a,b   Gupta, H ^a   Saluja, S ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b SJ Hospital   (India)

Author keywords

Afibrinogenemia; Congenital hypofibrinogenemia

Indexed keywords

FIBRINOGEN DEGRADATION PRODUCT;

ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CASE REPORT; CHILD; ECCHYMOSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPOFIBRINOGENEMIA; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBIN TIME;

AFIBRINOGENEMIA; BLOOD COAGULATION DISORDERS; CHILD; COMBINED MODALITY THERAPY; FEMALE; HEMORRHAGE; HUMANS; INDIA; PROGNOSIS; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 1342311353     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Leeners JV, Mossakowski J, Kayser S. Case report of congenital afibrinogenemia. Klin Pediatr 1995; 207: 34-35.
2. Al Mondhiry H, Ehman WC. Congenital afibrinogenemia. Am J Hematol 1994; 46: 343-347.
3. Mammen EF. Fibrinogen abnormalities. Semin Thromb Hemost 1988, 9: 1-6.
4. Khalid F, Taumi NH, Bouguerra F. Genetics study of congenital afibrinogenemia: review of 12 cases. Ann Pediatr 1999; 38: 461-467.
5. Ehman WC, Almondhiry H. Congenital afibrinogenemia and splenic rupture. Am J Med 1994; 96: 92-94.
6. Corrigan JJ. Phase III disorders: Hemorrhagic and Thrombotic Diseases. In: Nelson Textbook of Pediatrics, 15th edn: Eds Berman RE, Kliegman RM, Arvin AM, Nelson WE. United States of America, WB Saunders Company, 1996; pp 1428-1429.
7. Teitel JM. Algorithm for approach to therapy. Clin Lab Haem 2000, 22(Suppl. 1): 26-29.
8. Rodriguez RC, Buchnar GR, Clanton MS. Prophylactic cryoprecipitate in congenital afibrinogenemia. Clin Pediatric 1988; 207: 34-35.
9. Ingram GC, McBrien DJ, Spencer H. Fatal pulmonary embolism in congenital afibrinogenemia: report of 2 cases. Acta Hematol 1966, 35: 56-62.
10. Mackinnmon HH, Fehete JF. Congenital Afibrinogenemia: Vascular changes and multiple thrombosis induced by fibrinogen infusions and contraceptive medication. Can Med Assoc J 1971; 140: 547-549.